refers to the intensity rather than the duration of the inflammatory response so that a child with chronic disease may also show an increase in acute phase reactants, either intermittently or persistently.
The specificity of the acute phase response means that measurement of an increase in plasma concentration of acute phase proteins provides unequivocal evidence of inflammation and, because of the ubiquitous nature of inflammation, may therefore be used to detect a wide range of organic diseases. While bacterial infection is one of the most potent stimuli of the acute phase response, immunological, traumatic, ischaemic, or malignant damage to tissues usually evokes inflammation and thus a response. The magnitude of that response provides a guide to the intensity of inflammation or 
Acute disease and infection
When the clinical history is of less than 24 hours' duration, C-reactive protein is the acute phase protein of choice owing to its rapid response (6-10 hours) and large incremental increase from concentrations of less than 10 mg/l in normal serum (including that of premature infants and neonates). Typical serum concentrations would be: mild inflammation and severe viral infection, 10-40 mg/l; active inflammation and bacterial infection, 40-200 mg/l; and severe bacterial infection and burns, 200-400 mg/l.
Measurement of C-reactive protein is of particular value in paediatric practice as an indicator of invasive bacterial infection (viral infection causing little or no increase) and the subsequent fall in serum concentration (half time of 48 hours) on resolution of the inflammatory focus is useful for monitoring the efficacy of treatment. There is no absolute serum concentration of C-reactive protein that is diagnostic of bacterial infection, although 40 mg/l has been claimed to give higher specificity, with acceptable sensitivity, than 20 mg/l. In a study of 131 children who had been febrile for more than 12 hours, a serum concentration of 40 mg/l or more on admission had a sensitivity of 79% and a specificity of 90% for the detection of bacterial infection, while an erythrocyte sedimentation rate of 30 mm/hour or more had a sensitivity of 91% and a specificity of 89%. A similar study of infected neonates clearly showed that sensitivity varied with the level of C-reactive protein considered, the definition of infection used, and the time at which the blood was taken in the course of the disease.7 Specificity also depends on whether patients with obvious non-infective pathology are excluded from the study group, as they clearly should be,'4 and on whether serial measurements are made. '5 In a study of children with suspected meningitis a serum concentration of 20 mg/l or more indicated a bacterial rather than viral origin. 16 In immunocompromised patients with leukaemia concentrations of 30 mg/1l7 and 100 mg"'20 have been used to diagnose infection. In premature rupture of the membranes a C-reactive protein concentration of greater than 125 mg/l gave a positive predictive value of 96% and a negative predictive value of 89% for chorioamnionitis and, owing to the poor success rate of amniocentesis, was felt to be the more useful diagnostic test in this clinical situation. Interestingly the erythrocyte sedimentation rate showed a positive predictive value of 100% and a negative predictive value of 67% in this study. 
Conclusion
No one laboratory test satisfactorily reflects all aspects of the acute phase response and the choice of test is determined by the length of clinical history and the nature of the disease process. Serial measurement of C-reactive protein by a rapid, quantitative, and appropriately standardised assay is the test of choice for detecting and monitoring the acute phase protein response of acute inflammatory disorders such as infection in children. The assay is only worthwhile as a screening procedure for infection if the clinical context is well defined and other clinically detectable inflammatory diseases are excluded. With these provisos, a concentration of Creactive protein above 40 mg/l may be used to confirm infection, its diagnostic value increasing with time after the onset of symptoms to a maximum at 48 to 72 hours. In contrast, diagnosis and monitoring of chronic inflammatory disease is best undertaken by the measurement of erythrocyte sedimentation rate or plasma viscosity, although measurement of C-reactive protein may be useful in detecting an early response to treatment.
